Literature DB >> 30464221

Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers.

Andrew W McCrary1, Piers C A Barker1, Rachel D Torok1,2, Tracy G Spears2,3, Jennifer S Li1,2, Christoph P Hornik1,2, Matthew M Laughon4.   

Abstract

OBJECTIVE: To evaluate the agreement of an echocardiogram-based pulmonary hypertension diagnosis in premature infants at risk for bronchopulmonary dysplasia (BPD). STUDY
DESIGN: Echocardiograms from infants born ≤28 weeks post menstrual age were retrospectively reviewed with a standardized reading protocol by three pediatric cardiologists masked to patient's clinical history to determine the presence of pulmonary hypertension.
RESULTS: A total of 483 echocardiograms from 49 unique patients were each reviewed by three pediatric cardiologists. Overall there was an 82.9% agreement on the presence of pulmonary hypertension among the three readers (95% CI: 78.4%, 85.4%) with a modified Fleiss' kappa of 0.759 (95% CI: 0.711, 0.801). Percent agreement between rereads was 92.4%, and modified Fleiss' kappa was 0.847 (95% CI: 0.750, 0.931).
CONCLUSIONS: Using a standardized reading protocol and echocardiogram-based definition of pulmonary hypertension, there is high inter- and intra-rater agreement for the diagnosis of pulmonary hypertension in at-risk premature infants, suggesting echocardiography can be successfully used for clinical and research monitoring of pulmonary hypertension in infants.

Entities:  

Mesh:

Year:  2018        PMID: 30464221      PMCID: PMC6724723          DOI: 10.1038/s41372-018-0277-6

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  1 in total

Review 1.  Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia - A review of the literature.

Authors:  Gabriel Altit; Adrian Dancea; Claudia Renaud; Thérèse Perreault; Larry C Lands; Guilherme Sant'Anna
Journal:  Paediatr Respir Rev       Date:  2016-11-09       Impact factor: 2.726

  1 in total
  5 in total

1.  Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia.

Authors:  Shilpa Vyas-Read; Erica M Wymore; Isabella Zaniletti; Karna Murthy; Michael A Padula; William E Truog; William A Engle; Rashmin C Savani; Sushmita Yallapragada; J Wells Logan; Huayan Zhang; Erik B Hysinger; Theresa R Grover; Girija Natarajan; Leif D Nelin; Nicolas F M Porta; Karin P Potoka; Robert DiGeronimo; Joanne M Lagatta
Journal:  J Perinatol       Date:  2019-09-30       Impact factor: 2.521

2.  Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study.

Authors:  Simone Schneider; Mary Bailey; Tracy Spears; Charles R Esther; Matthew M Laughon; Christoph P Hornik; Wesley Jackson
Journal:  BMC Pediatr       Date:  2020-12-14       Impact factor: 2.125

3.  Early cardiac dysfunction in children and young adults with perinatally acquired HIV.

Authors:  Andrew W McCrary; Winstone M Nyandiko; Alicia M Ellis; Hrishikesh Chakraborty; Michael J Muehlbauer; Myra M Koech; Ibrahim Daud; Elcy Birgen; Nathan M Thielman; Joseph A Kisslo; Piers C A Barker; Gerald S Bloomfield
Journal:  AIDS       Date:  2020-03-15       Impact factor: 4.632

4.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

5.  Dual-specificity phosphatase (DUSP) genetic variants predict pulmonary hypertension in patients with bronchopulmonary dysplasia.

Authors:  Lauren L Chen; Erik J Zmuda; Maria M Talavera; Jessica Frick; Guy N Brock; Yusen Liu; Mark A Klebanoff; Jennifer K Trittmann
Journal:  Pediatr Res       Date:  2019-07-22       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.